Novartis in Society Integrated Report 2022

Global Reporting Initiative (GRI) Index

Disclosure Number

Disclosure Title

Reference

GRI 1

Foundation 2021

GRI 2

General disclosures 2021

The organization and its reporting practices

2-1

Organization details

Annual Report 2022, p. 21
Our global operations

2-2

Entities included in the organization’s sustainability reporting

Our approach to reporting

2-3

Reporting period, frequency and contact point

Our approach to reporting

2-4

Restatements of information

About this report

2-5

External assurance

Independent limited assurance report on selected Sustainability Information of Novartis AG

Activities and workers

2-6

Activities, value chain and other business relationships

Our company
How we create value

2-7

Employees

Unleash the power of our people
People performance indicators

2-8

Workers who are not employees

People performance indicators

Governance

2-9

Governance structure and composition

Corporate governance
Our Board of Directors

2-10

Nomination and selection of the highest governance body

Corporate governance
Annual Report 2022, p. 130

2-11

Chair of the highest governance body

Annual Report 2022, p. 130

2-12

Role of the highest governance body in overseeing the management of impacts

Corporate governance
ESG and material topic governance

2-13

Delegation of responsibility for managing impacts

Corporate governance
ESG and material topic governance

2-14

Role of the highest governance body in sustainability reporting

Our approach to reporting

2-15

Conflicts of interest

Annual Report 2022, p. 143

2-16

Communication of critical concerns

Maintaining high ethical standards
Upholding our commitment to human rights
People performance indicators

2-17

Collective knowledge of the highest governance body

Corporate governance

2-18

Evaluation of the performance of the highest governance body

Corporate governance

2-19

Remuneration policies

Compensation Report

2-20

Process to determine remuneration

Corporate governance

2-21

Annual total compensation ratio

Confidentiality constraints:
Novartis does not publicly disclose this data.

Strategy, policies and practices

2-22

Statement on sustainable development strategy

Chair’s letter
Our strategy

2-23

Policy commitments

Build trust with society
Maintaining high ethical standards
Upholding our commitment to human rights

2-24

Embedding policy commitments

Build trust with society
Maintaining high ethical standards
Upholding our commitment to human rights

2-25

Processes to remediate negative impacts

Stakeholder engagement
Maintaining high ethical standards
Upholding our commitment to human rights

2-26

Mechanisms for seeking advice and raising concerns

Build trust with society
Third-party risk assessments

2-27

Compliance with laws and regulations

Annual Report 2022, F-44

2-28

Membership associations

Maintaining high ethical standards

Stakeholder engagement

2-29

Approach to stakeholder engagement

Stakeholder engagement

2-30

Collective bargaining agreements

Unleash the power of our people

Disclosure Number

Disclosure Title

Reference

GRI 3

Material topics 2021

3-1

Process to determine material topics

Our material issues

3-2

List of material topics

Our material issues

3-3

Management of material topics

Performance in 2022

Disclosure Number

Disclosure Title

Reference

GRI 201

Economic Performance 2016

201-1

Direct economic value generated and distributed

Annual Report 2022, F-1 – F80

201-2

Financial implications and other risks and opportunities due to climate change

Task Force on Climate-Related Financial Disclosures (TCFD)

201-3

Defined benefit plan obligations and other retirement plans

Annual Report 2022, F-53

201-4

Financial assistance received from government

Annual Report 2022, F-1 – F80

GRI 203

Indirect Economic Impacts 2016

203-1

Infrastructure investments and services supported

Affordability and availability
Annual Report 2022, F-1 – F80

203-2

Significant indirect economic impacts

How we create value

GRI 205

Anti-Corruption 2016

205-1

Operations assessed for risks related to corruption

Supply chain management
Ethics, risk and compliance

205-2

Communication and training about anti-corruption policies and procedures

Maintaining high ethical standards
Third-party risk assessments

205-3

Confirmed incidents of corruptions and actions taken

Ethical business practices performance indicators

GRI 206

Anti-Competitive Behavior 2016

206-1

Legal actions for anti-competitive behavior, anti-trust, and monopoly practices

Annual Report 2022, F-45

GRI 207

Tax (2019)

207-1

Approach to tax

Novartis Tax Policy Statement (updated June 2022)

207-2

Tax governance, control, and risk management

Maintaining high ethical standards
Novartis Tax Policy Statement (updated June 2022)

207-3

Stakeholder engagement and management of concerns related to tax

Novartis Tax Policy Statement (updated June 2022)

207-4

Country-by-country reporting

Confidentiality constraints:
Novartis does not publicly disclose this data.

Disclosure Number

Disclosure Title

Reference

GRI 301

Materials 2016

301-1

Materials used by weight or volume

Environment performance indicators

301-2

Recycled input materials used

Environmental sustainability

301-3

Reclaimed products and their packaging materials

Environmental sustainability

GRI 302

Energy 2016

302-1

Energy consumption within the organization

Environment performance indicators

302-2

Energy consumption outside of the organization

Environment performance indicators

302-3

Energy intensity

Environment performance indicators

302-4

Reduction of energy consumption

Environment performance indicators

302-5

Reductions in energy requirements of products and services

Environmental sustainability

GRI 305

Emissions 2016

305-1

Direct (Scope 1) GHG emissions

Environment performance indicators

305-2

Energy indirect (Scope 2) GHG emissions

Environment performance indicators

305-3

Other indirect (Scope 3) GHG emissions

Environment performance indicators

305-4

GHG emissions intensity

Environmental sustainability
Environment performance indicators

305-5

Reduction of GHG emissions

Environment performance indicators

305-6

Emissions of ozone-depleting substances (ODS)

Environmental performance indicators

305-7

Nitrogen oxides (NoX), sulfur oxides (SoX), and other significant air emissions

Environmental performance indicators

GRI 306

Waste 2020

306-1

Waste generation and significant waste-related impacts

Environmental sustainability

306-2

Management of significant waste-related impacts

Environmental sustainability
Environment performance indicators

306-3

Waste generated

Environment performance indicators

306-4

Waste diverted from disposal

Environment performance indicators

306-5

Waste directed to disposal

Environment performance indicators

GRI 308

Supplier Environmental Assessment 2016

308-1

New suppliers that were screened using environmental criteria

Environmental sustainability

308-2

Negative environmental impacts in the supply chain and actions taken

Environmental sustainability
Environmental sustainability criteria for suppliers

Disclosure Number

Disclosure Title

Reference

GRI 401

Employment 2016

401-1

New employee hires and employee turnover

People performance indicators

401-2

Benefits provided to full-time employees that are not provided to temporary or part-time employees

Wages and cost of living

401-3

Parental leave

Diversity, equity and inclusion (DEI)

GRI 403

Occupational health & safety 2018

403-1

Occupational health and safety management system

Wages and cost of living
People performance indicators

403-2

Hazard identification, risk assessment, and incident investigation

Scale data science and technology
People performance indicators

403-3

Occupational health services

Scale data science and technology
People performance indicators

403-4

Worker participation, consultation, and communication on occupational health and safety

HSE policy

403-5

Worker training on occupational health and safety

Wages and cost of living

403-6

Promotion of worker health

Unleash the power of our people

403-7

Prevention and mitigation of occupational health and safety impacts directly linked by business relationships

Wages and cost of living

403-8

Workers covered by an occupational health and safety management system

Wages and cost of living

403-9

Work-related injuries

Wages and cost of living

403-10

Work-related ill health

Wages and cost of living

GRI 404

Training and Education 2016

404-1

Average hours of training per year per employee

Learning, growth and leadership development

404-2

Programs for upgrading employee skills and transition assistance programs

Learning, growth and leadership development

404-3

Percentage of employees receiving regular performance and career development reviews

 

GRI 405

Diversity and Equal Opportunity 2016

405-1

Diversity of governance bodies and employees

Our Board of Directors
People performance indicators

405-2

Ratio of basic salary and remuneration of women to men

Diversity, equity and inclusion (DEI)

GRI 406

Non-Discrimination 2016

406-1

Incidents of discrimination and corrective actions taken

People performance indicators

GRI 407

Freedom of Association and Collective Bargaining 2016

407-1

Operations and suppliers in which the right to freedom of association and collective bargaining may be at risk

Unleash the power of our people
People performance indicators

GRI 413

Local Communities 2016

413-1

Operations with local community engagement, impact assessments, and development programs

Health system strengthening

413-2

Operations with significant actual and potential negative impacts on local communities

Environmental sustainability

GRI 414

Supplier Social Assessment 2016

414-1

New suppliers that were screened using social criteria

Supply chain management

414-2

Negative social impacts in the supply chain and actions take

Supply chain management

GRI 416

Customer Health and Safety 2016

416-1

Assessment of the health and safety impacts of product and service categories

Protecting patient health and safety

416-2

Incidents of non-compliance concerning the health and safety impacts of products and services

Protecting patient health and safety

GRI 417

Marketing and Labeling 2016

417-1

Requirements for product and service information and labeling

Protecting patient health and safety

417-2

Incidents of non-compliance concerning product and service information and labeling

Protecting patient health and safety

417-3

Incidents of non-compliance concerning marketing communications

Maintaining high ethical standards

GRI 418

Customer Privacy 2016

418-1

Substantiated complaints concerning breaches of customer privacy and losses of customer data

Ethical business practices performance indicators

Topic filter